Bauer Margaret E, Townsend Carisa A, Doster Ryan S, Fortney Kate R, Zwickl Beth W, Katz Barry P, Spinola Stanley M, Janowicz Diane M
Departments of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, USA.
J Infect Dis. 2009 Mar 1;199(5):684-92. doi: 10.1086/596656.
A gene expression study of Haemophilus ducreyi identified the hypothetical lipoprotein HD0192, renamed here "fibrinogen binder A" (FgbA), as being preferentially expressed in vivo. To test the role played by fgbA in virulence, an isogenic fgbA mutant (35000HPfgbA) was constructed using H. ducreyi 35000HP, and 6 volunteers were experimentally infected with 35000HP or 35000HPfgbA. The overall pustule-formation rate was 61.1% at parent sites and 22.2% at mutant sites (P = .019). Papules were significantly smaller at mutant sites than at parent sites (13.3 vs. 37.9 mm(2); P = .002) 24 h after inoculation. Thus, fgbA contributed significantly to the virulence of H. ducreyi in humans. In vitro experiments demonstrated that fgbA encodes a fibrinogen-binding protein; no other fibrinogen-binding proteins were identified in 35000HP. fgbA was conserved among clinical isolates of both class I and II H. ducreyi strains, supporting the finding that fgbA is important for H. ducreyi infection.
一项针对杜克雷嗜血杆菌的基因表达研究确定,假定的脂蛋白HD0192(在此重新命名为“纤维蛋白原结合蛋白A”,即FgbA)在体内优先表达。为了测试fgbA在毒力中所起的作用,利用杜克雷嗜血杆菌35000HP构建了一个同基因fgbA突变体(35000HPfgbA),并对6名志愿者进行了35000HP或35000HPfgbA的实验性感染。在亲本部位的总体脓疱形成率为61.1%,在突变体部位为22.2%(P = 0.019)。接种24小时后,突变体部位的丘疹明显小于亲本部位(13.3对37.9平方毫米;P = 0.002)。因此,fgbA对杜克雷嗜血杆菌在人类中的毒力有显著贡献。体外实验表明,fgbA编码一种纤维蛋白原结合蛋白;在35000HP中未鉴定出其他纤维蛋白原结合蛋白。fgbA在I类和II类杜克雷嗜血杆菌临床分离株中是保守的,这支持了fgbA对杜克雷嗜血杆菌感染很重要这一发现。